ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Detail of the clinical trial

Title of the trial A Phase 3 (Pivotal Stage) Study of NBTXR3 Activated by Investigator?s Choice of Radiotherapy Alone or Radiotherapy in Combination with Cetuximab for platinum-based Chemotherapy-ineligible Elderly Patients with Locally Advanced Head & Neck Squamous Cell Carcinoma
EudraCT number 2021-002163-22
Protocol number NANORAY-312
Sponsor NANOBIOTIX, 60 rue de Wattignies, 750 12 Paris, France
Indications Oncology
Diagnosis head and neck carcinoma
Population in clinical trial Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2021
Date of approval by Institute (SÚKL) 2.12.2021
Date of approval by EC 10.1.2022
Date of initiation CT in ČR 9.11.2022
Date of ending CT in ČR
Sites Fakultní nemocnice Bulovka, Ústav radiační onkologie,Budínova 2,Praha 8,180 81
Fakultní nemocnice Olomouc, Onkologická klinika,I. P. Pavlova 185/6,Olomouc,779 00

‹‹ Back to list